Category: Q4Syndicate content

Alphatec settles OrthoTec beef for $49M

March 18, 2014 by Brad Perriello

Alphatec said it agreed to settle a legal dispute with OrthoTec for $49 million paid over 7 years and meets Wall Street's expectations for its 4th-quarter earnings.

Alphatec settles OrthoTec beef for $49M

Alphatec (NSDQ:ATEC) said it agreed to pay $49 million over 7 years to settle a legal dispute with OrthoTec and beat Wall Street's forecast for its 4th-quarter earnings.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cantel Medical slides despite Street-beating Q2

March 12, 2014 by Brad Perriello

Shares of Cantel Medical come under pressure despite strong fiscal 2nd-quarter results that beat expectations on Wall Street.

Cantel Medical slides despite Street-beating Q2

Cantel Medical (NYSE:CMN) shares are down nearly 4% this morning after the medical device company reported its fiscal 2nd-quarter results.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase cuts costs ahead of a potential sale, posts losses in Q4

March 11, 2014 by Arezu Sarvestani

Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.

Biolase cuts costs ahead of a potential sale, posts losses in Q4

California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

March 10, 2014 by Arezu Sarvestani

The medtech giant formed by the merger of Kinetic Concepts, LifeCell Corp. and Systagenix swings to the red in Q4 amid a near 7% boost in sales.

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive shares jump on Street-beating Q4 numbers

March 4, 2014 by Brad Perriello

Shares of NuVasive jump on Wall Street today after the medical device company reports earnings ahead of analysts' expectations.

NuVasive shares jump on Street-beating Q4 numbers

NuVasive Inc. (NSDQ:NUVA) shares gained nearly 8% today after the medical device company reported beating expectations with its 4th-quarter earnings as it swung to black ink.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

State AGs subpoena Endo Health over pelvic mesh products

March 3, 2014 by Brad Perriello

Endo Health Solutions says the attorneys general from several states including California are investigating its pelvic mesh products; 4th-quarter earnings beat expectations, but Endo's outlook disappoints Wall Street.

State AGs subpoena Endo Health over pelvic mesh products

Endo Health Solutions (NSDQ:ENDP) said its pelvic mesh products are under investigation by the attorneys general from several states including California.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet boosts sales, slashes losses, notes Mass. state inquiry

February 28, 2014 by Arezu Sarvestani

Diabetes devices maker Insulet posts a stellar quarter that beats Wall Street's expectations and notes a pending Massachusetts Attorney General inquiry.

Diabetes: Insulet gains on boost in sales, narrowing losses in Q4 and 2013

Massachusetts-based Insulet (NSDQ:PODD) got some Wall Street love today after posing a significant bump in sales for its 4th quarter and the full year of 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp